These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


372 related items for PubMed ID: 25756522

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E, Ferrières J.
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels.
    Kataoka Y, Hammadah M, Puri R, Duggal B, Uno K, Kapadia SR, Murat Tuzcu E, Nissen SE, Nicholls SJ.
    Atherosclerosis; 2015 Oct; 242(2):490-5. PubMed ID: 26298740
    [Abstract] [Full Text] [Related]

  • 26. Begin with the real-world patients of non-goal-achieved hypercholesterolemia in taiwan through the ezetimibe/simvastatin tablet - The BRAVO Study.
    Huang JC, Lee TY, Liou MJ, Lin CM, Pei D, Chen ZC, Liu RT, Kwok CF.
    Curr Med Res Opin; 2011 Aug; 27(8):1645-51. PubMed ID: 21699369
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S, Logunova N, Khomitskaya Y, CEPHEUS II investigators.
    Cardiovasc Diabetol; 2017 Dec 16; 16(1):158. PubMed ID: 29246151
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Achieving target cholesterol levels in diabetic patients: potency of the statin or potency of the physician?
    Shani M, Dresner J, Vinker S.
    Isr Med Assoc J; 2008 May 16; 10(5):354-7. PubMed ID: 18605358
    [Abstract] [Full Text] [Related]

  • 34. Assessment of compliance with lipid guidelines in an academic medical center.
    Schwiesow SJ, Nappi JM, Ragucci KR.
    Ann Pharmacother; 2006 Jan 16; 40(1):27-31. PubMed ID: 16352778
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lipid attainment among patients newly treated with lipid-altering drugs.
    Hess G, Chang CL, Chung K.
    Curr Med Res Opin; 2014 Sep 16; 30(9):1743-56. PubMed ID: 24889282
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.